|
G |
A2M |
alpha-2-macroglobulin |
decreases expression |
EXP |
potassium bromate results in decreased expression of A2M mRNA |
CTD |
PMID:30008028 |
|
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
|
|
G |
ADH1A |
alcohol dehydrogenase 1A (class I), alpha polypeptide |
decreases expression |
EXP |
potassium bromate results in decreased expression of ADH1A mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 4:99,276,369...99,290,985
Ensembl chr 4:99,276,369...99,291,003
|
|
G |
AGTR2 |
angiotensin II receptor type 2 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974
|
|
G |
AKR1B10 |
aldo-keto reductase family 1 member B10 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AKR1B10 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
|
|
G |
AKR1C2 |
aldo-keto reductase family 1 member C2 |
increases expression |
ISO |
potassium bromate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
ISO |
Squalene inhibits the reaction [potassium bromate results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:33219891 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
AMIGO2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
EXP |
potassium bromate results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr12:47,075,707...47,079,959
Ensembl chr12:47,075,707...47,079,959
|
|
G |
ANOS1 |
anosmin 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of WFDC17 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr X:8,528,874...8,732,137
Ensembl chr X:8,528,874...8,732,137
|
|
G |
APEX1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
EXP |
potassium bromate results in increased expression of APEX1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
|
|
G |
APP |
amyloid beta precursor protein |
increases expression |
EXP |
potassium bromate results in increased expression of APP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
AREG |
amphiregulin |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AREG mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
|
|
G |
ARG1 |
arginase 1 |
decreases expression |
EXP |
potassium bromate results in decreased expression of ARG1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
|
|
G |
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
affects expression |
EXP |
potassium bromate affects the expression of ASNS mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
|
|
G |
ATF3 |
activating transcription factor 3 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of ATF3 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA] |
CTD |
PMID:23588252 PMID:27082013 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
ATM |
ATM serine/threonine kinase |
decreases expression |
EXP |
potassium bromate results in decreased expression of ATM mRNA |
CTD |
PMID:22539617 |
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
|
|
G |
ATP1B1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
EXP |
potassium bromate results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 1:169,106,690...169,132,719
Ensembl chr 1:169,105,697...169,310,992
|
|
G |
ATP2B3 |
ATPase plasma membrane Ca2+ transporting 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of ATP2B3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr X:153,517,642...153,582,929
Ensembl chr X:153,517,642...153,582,939
|
|
G |
BAAT |
bile acid-CoA:amino acid N-acyltransferase |
decreases expression |
EXP |
potassium bromate results in decreased expression of BAAT mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 9:101,360,417...101,385,006
Ensembl chr 9:101,354,182...101,385,400
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of BAX mRNA potassium bromate results in increased expression of BAX protein Squalene promotes the reaction [potassium bromate results in increased expression of BAX protein] |
CTD |
PMID:30559759 PMID:33219891 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBOX1 |
gamma-butyrobetaine hydroxylase 1 |
decreases expression |
EXP |
potassium bromate results in decreased expression of BBOX1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr11:27,040,815...27,127,809
Ensembl chr11:27,040,725...27,127,809
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions increases expression |
ISO |
Squalene inhibits the reaction [potassium bromate results in increased expression of BCL2 protein] |
CTD |
PMID:33219891 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BLNK |
B cell linker |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of BLNK mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BLNK mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:96,189,171...96,271,569
Ensembl chr10:96,189,171...96,271,587
|
|
G |
BMF |
Bcl2 modifying factor |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of BMF mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BMF mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
|
|
G |
BRCA1 |
BRCA1 DNA repair associated |
increases expression |
EXP |
potassium bromate results in increased expression of BRCA1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
|
|
G |
CA3 |
carbonic anhydrase 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CA3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
|
|
G |
CA6 |
carbonic anhydrase 6 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CAR6 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:8,945,868...8,975,092
Ensembl chr 1:8,945,867...8,975,092
|
|
G |
CARS1 |
cysteinyl-tRNA synthetase 1 |
decreases expression |
EXP |
potassium bromate results in decreased expression of CARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613
|
|
G |
CASP3 |
caspase 3 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of CASP3 protein Squalene promotes the reaction [potassium bromate results in increased expression of CASP3 protein] |
CTD |
PMID:33219891 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
decreases activity multiple interactions increases activity |
EXP ISO |
potassium bromate results in decreased activity of CAT protein vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein] Arbutin inhibits the reaction [potassium bromate results in decreased activity of CAT protein]; Squalene inhibits the reaction [potassium bromate results in decreased activity of CAT protein]; Taurine inhibits the reaction [potassium bromate results in decreased activity of CAT protein] |
CTD |
PMID:22012894 PMID:25213677 PMID:26296324 PMID:27074584 PMID:33219891 PMID:36284482 More...
|
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of CCL20 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CCL20 mRNA] |
CTD |
PMID:23588252 PMID:27082013 |
|
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
CCNB1 |
cyclin B1 |
multiple interactions increases expression |
EXP |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CCNB1 protein] |
CTD |
PMID:20067818 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCNO |
cyclin O |
decreases expression |
EXP |
potassium bromate results in decreased expression of CCNO mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 5:55,231,152...55,233,608
Ensembl chr 5:55,231,152...55,233,608
|
|
G |
CDHR1 |
cadherin related family member 1 |
increases expression |
ISO |
potassium bromate results in increased expression of CDHR1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr10:84,194,537...84,219,621
Ensembl chr10:84,194,537...84,219,621
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
increases phosphorylation |
EXP |
potassium bromate results in increased phosphorylation of CDK1 protein |
CTD |
PMID:20067818 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression affects methylation affects expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of CDKN1A mRNA; potassium bromate results in increased expression of CDKN1A protein potassium bromate affects the methylation of CDKN1A gene potassium bromate affects the expression of CDKN1A mRNA; potassium bromate affects the expression of CDKN1A protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Azacitidine inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; trichostatin A inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein] |
CTD |
PMID:20067818 PMID:23588252 PMID:23811332 PMID:25015661 PMID:30008028 PMID:30559759 More...
|
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CFD |
complement factor D |
decreases expression |
ISO |
potassium bromate results in decreased expression of CFD mRNA |
CTD |
PMID:23588252 |
|
NCBI chr19:859,664...863,641
Ensembl chr19:859,453...867,884
|
|
G |
CHAC1 |
ChaC glutathione specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
potassium bromate results in increased expression of CHAC1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512
|
|
G |
CLDN2 |
claudin 2 |
decreases expression |
EXP |
potassium bromate results in decreased expression of CLDN2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr X:106,900,164...106,930,861
Ensembl chr X:106,900,164...106,930,861
|
|
G |
CLU |
clusterin |
increases expression |
ISO |
potassium bromate results in increased expression of CLU protein |
CTD |
PMID:23159986 PMID:23588252 PMID:23811332 |
|
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
|
|
G |
COCH |
cochlin |
decreases expression |
ISO |
potassium bromate results in decreased expression of COCH mRNA |
CTD |
PMID:23588252 |
|
NCBI chr14:30,874,559...30,895,615
Ensembl chr14:30,874,514...30,895,065
|
|
G |
COMT |
catechol-O-methyltransferase |
increases expression |
ISO |
potassium bromate results in increased expression of COMT mRNA |
CTD |
PMID:23588252 |
|
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
|
|
G |
CSRP3 |
cysteine and glycine rich protein 3 |
increases expression |
ISO |
potassium bromate results in increased expression of CSRP3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr11:19,182,030...19,201,983
Ensembl chr11:19,182,030...19,210,571
|
|
G |
CTH |
cystathionine gamma-lyase |
increases methylation |
EXP |
potassium bromate results in increased methylation of CTH promoter |
CTD |
PMID:30559759 |
|
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CXCL3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CYP2D6 |
cytochrome P450 family 2 subfamily D member 6 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of CYP2D22 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
decreases expression |
EXP |
potassium bromate results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
DDB2 |
damage specific DNA binding protein 2 |
increases expression |
EXP |
potassium bromate results in increased expression of DDB2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:47,214,454...47,239,217
Ensembl chr11:47,214,465...47,239,217
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression |
EXP |
potassium bromate results in increased expression of DDIT3 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DIO3 |
iodothyronine deiodinase 3 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
|
|
G |
DSC1 |
desmocollin 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of DSC1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr18:31,129,236...31,162,856
Ensembl chr18:31,129,236...31,162,856
|
|
G |
DUSP2 |
dual specificity phosphatase 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of DUSP2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:96,143,169...96,145,440
Ensembl chr 2:96,143,169...96,145,440
|
|
G |
EGR4 |
early growth response 4 |
multiple interactions affects expression |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:73,290,929...73,293,548
Ensembl chr 2:73,290,929...73,293,701
|
|
G |
ERCC4 |
ERCC excision repair 4, endonuclease catalytic subunit |
decreases expression |
EXP |
potassium bromate results in decreased expression of ERCC4 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr16:13,920,154...13,952,348
Ensembl chr16:13,920,138...13,952,348
|
|
G |
ERCC6 |
ERCC excision repair 6, chromatin remodeling factor |
affects response to substance multiple interactions |
EXP |
ERCC6 protein affects the susceptibility to potassium bromate veliparib promotes the reaction [ERCC6 protein affects the susceptibility to potassium bromate] |
CTD |
PMID:25136123 |
|
NCBI chr10:49,434,881...49,539,538
Ensembl chr10:49,454,168...49,539,538
|
|
G |
EREG |
epiregulin |
increases expression |
EXP |
potassium bromate results in increased expression of EREG mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
|
|
G |
FAS |
Fas cell surface death receptor |
increases expression |
EXP |
potassium bromate results in increased expression of FAS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FBXO22 |
F-box protein 22 |
increases expression |
EXP |
potassium bromate results in increased expression of FBXO22 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr15:75,903,878...75,942,511
Ensembl chr15:75,903,876...75,942,511
|
|
G |
FEN1 |
flap structure-specific endonuclease 1 |
decreases expression |
EXP |
potassium bromate results in decreased expression of FEN1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr11:61,792,911...61,797,238
Ensembl chr11:61,792,911...61,797,238
|
|
G |
FGB |
fibrinogen beta chain |
increases expression |
ISO |
potassium bromate results in increased expression of FGB mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
|
|
G |
FGL2 |
fibrinogen like 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of FGL2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848
|
|
G |
FRY |
FRY microtubule binding protein |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of FRY mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr13:32,031,774...32,299,125
Ensembl chr13:31,846,713...32,299,125
|
|
G |
FTH1 |
ferritin heavy chain 1 |
increases expression |
EXP |
potassium bromate results in increased expression of FTH1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
|
|
G |
FZD2 |
frizzled class receptor 2 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr17:44,557,484...44,561,262
Ensembl chr17:44,557,484...44,561,262
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
multiple interactions decreases activity |
ISO |
Taurine inhibits the reaction [potassium bromate results in decreased activity of G6PD protein] |
CTD |
PMID:25213677 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression |
EXP |
potassium bromate results in increased expression of GADD45A mRNA |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
increases expression increases methylation |
EXP |
potassium bromate results in increased expression of GCLM mRNA potassium bromate results in increased methylation of GCLM promoter |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GCNT3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
EXP |
potassium bromate results in increased expression of GCNT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr15:59,549,039...59,622,723
Ensembl chr15:59,594,875...59,640,239
|
|
G |
GPR87 |
G protein-coupled receptor 87 |
increases expression |
EXP |
potassium bromate results in increased expression of GPR87 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:151,294,086...151,316,820
Ensembl chr 3:151,294,086...151,316,820
|
|
G |
GPT |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
ISO |
potassium bromate results in increased activity of GPT protein Squalene inhibits the reaction [potassium bromate results in increased activity of GPT protein] |
CTD |
PMID:33219891 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GRIFIN |
galectin-related inter-fiber protein |
decreases expression |
ISO |
potassium bromate results in decreased expression of GRIFIN mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 7:2,474,728...2,476,398
Ensembl chr 7:2,474,728...2,476,894
|
|
G |
GSR |
glutathione-disulfide reductase |
decreases activity multiple interactions |
EXP ISO |
potassium bromate results in decreased activity of GSR protein Squalene inhibits the reaction [potassium bromate results in decreased activity of GSR protein]; Taurine inhibits the reaction [potassium bromate results in decreased activity of GSR protein] |
CTD |
PMID:22012894 PMID:25213677 PMID:33219891 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSTA5 |
glutathione S-transferase alpha 5 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of GSTA5 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
|
|
G |
H2AX |
H2A.X variant histone |
multiple interactions increases phosphorylation |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein; bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein] potassium bromate results in increased phosphorylation of H2AX protein Azacitidine inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein]; trichostatin A inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein] |
CTD |
PMID:25015661 PMID:25693136 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
HAVCR1 |
hepatitis A virus cellular receptor 1 |
increases expression |
ISO |
potassium bromate results in increased expression of HAVCR1 mRNA; potassium bromate results in increased expression of HAVCR1 protein |
CTD |
PMID:23588252 PMID:23811332 |
|
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions increases expression |
EXP |
ceric oxide inhibits the reaction [potassium bromate results in increased expression of HMOX1 mRNA] |
CTD |
PMID:25618551 PMID:30008028 PMID:30559759 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
decreases expression increases expression |
EXP |
potassium bromate results in decreased expression of HNF4A mRNA potassium bromate results in increased expression of HNF4A mRNA |
CTD |
PMID:30008028 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
HP |
haptoglobin |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of HP mRNA [potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of HP mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
|
|
G |
HPGD |
15-hydroxyprostaglandin dehydrogenase |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HPGD mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
|
|
G |
HPR |
haptoglobin-related protein |
decreases expression |
EXP |
potassium bromate results in decreased expression of HPR mRNA |
CTD |
PMID:30008028 |
|
NCBI chr16:72,063,226...72,077,246
Ensembl chr16:72,063,148...72,077,246
|
|
G |
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 |
increases mutagenesis |
EXP ISO |
potassium bromate results in increased mutagenesis of HPRT1 gene |
CTD |
PMID:19853637 PMID:22539617 |
|
NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,165...134,520,513
|
|
G |
IGFBP1 |
insulin like growth factor binding protein 1 |
increases expression |
ISO |
potassium bromate results in increased expression of IGFBP1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
|
|
G |
IKZF2 |
IKAROS family zinc finger 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of IKZF2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IKZF2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:212,999,698...213,152,456
Ensembl chr 2:212,999,691...213,152,427
|
|
G |
IL18R1 |
interleukin 18 receptor 1 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of IL18R1 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IL18R1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:102,355,796...102,398,776
Ensembl chr 2:102,311,529...102,398,777
|
|
G |
IL1B |
interleukin 1 beta |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of IL1B mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mRNA] |
CTD |
PMID:23588252 PMID:26296324 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL24 |
interleukin 24 |
increases expression |
ISO |
potassium bromate results in increased expression of IL24 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
|
|
G |
IL6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of IL6 mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
KAT2B |
lysine acetyltransferase 2B |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:20,040,446...20,154,404
Ensembl chr 3:20,040,446...20,154,404
|
|
G |
KIRREL3 |
kirre like nephrin family adhesion molecule 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of KIRREL3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr11:126,423,358...127,000,870
Ensembl chr11:126,423,358...127,003,460
|
|
G |
KLF15 |
KLF transcription factor 15 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of KLF15 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:126,288,125...126,357,408
Ensembl chr 3:126,342,635...126,357,408
|
|
G |
LCN2 |
lipocalin 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
|
|
G |
LGALS12 |
galectin 12 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr11:63,506,084...63,516,772
Ensembl chr11:63,506,052...63,516,774
|
|
G |
LIG3 |
DNA ligase 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of LIG3 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr17:34,980,512...35,010,872
Ensembl chr17:34,980,512...35,009,743
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
potassium bromate results in increased phosphorylation of and results in increased activity of MAPK1 protein |
CTD |
PMID:20067818 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
potassium bromate results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:20067818 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MDM2 |
MDM2 proto-oncogene |
increases expression |
EXP |
potassium bromate results in increased expression of MDM2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
ME1 |
malic enzyme 1 |
increases expression |
EXP |
potassium bromate results in increased expression of ME1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
|
|
G |
MED1 |
mediator complex subunit 1 |
decreases phosphorylation |
EXP |
potassium bromate results in decreased phosphorylation of MED1 protein |
CTD |
PMID:25068892 |
|
NCBI chr17:39,404,285...39,451,263
Ensembl chr17:39,404,285...39,451,272
|
|
G |
MIR1181 |
microRNA 1181 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR1181 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:10,403,458...10,403,538
Ensembl chr19:10,403,458...10,403,538
|
|
G |
MIR1225 |
microRNA 1225 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR1225 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr16:2,090,195...2,090,284
Ensembl chr16:2,090,195...2,090,284
|
|
G |
MIR126 |
microRNA 126 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR126 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:136,670,602...136,670,686
Ensembl chr 9:136,670,602...136,670,686
|
|
G |
MIR134 |
microRNA 134 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR134 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:101,054,687...101,054,759
Ensembl chr14:101,054,687...101,054,759
|
|
G |
MIR137 |
microRNA 137 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR137 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:98,046,070...98,046,171
Ensembl chr 1:98,046,070...98,046,171
|
|
G |
MIR146B |
microRNA 146b |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR146B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:102,436,512...102,436,584
Ensembl chr10:102,436,512...102,436,584
|
|
G |
MIR1915 |
microRNA 1915 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR1915 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:21,496,562...21,496,641
Ensembl chr10:21,496,562...21,496,641
|
|
G |
MIR193A |
microRNA 193a |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR193A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:31,559,996...31,560,083
Ensembl chr17:31,559,996...31,560,083
|
|
G |
MIR193B |
microRNA 193b |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR193B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr16:14,303,967...14,304,049
Ensembl chr16:14,303,967...14,304,049
|
|
G |
MIR197 |
microRNA 197 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR197 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:109,598,893...109,598,967
Ensembl chr 1:109,598,893...109,598,967
|
|
G |
MIR205 |
microRNA 205 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR205 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:209,432,133...209,432,242
Ensembl chr 1:209,432,133...209,432,242
|
|
G |
MIR21 |
microRNA 21 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR21 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
G |
MIR23B |
microRNA 23b |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR23B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:95,085,208...95,085,304
Ensembl chr 9:95,085,208...95,085,304
|
|
G |
MIR24-1 |
microRNA 24-1 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR24-1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:95,086,021...95,086,088
Ensembl chr 9:95,086,021...95,086,088
|
|
G |
MIR29B1 |
microRNA 29b-1 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:130,877,459...130,877,539
Ensembl chr 7:130,877,459...130,877,539
|
|
G |
MIR331 |
microRNA 331 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR331 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:95,308,420...95,308,513
Ensembl chr12:95,308,420...95,308,513
|
|
G |
MIR3663 |
microRNA 3663 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR3663 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:117,167,678...117,167,774
Ensembl chr10:117,167,678...117,167,774
|
|
G |
MIR3665 |
microRNA 3665 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR3665 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:77,698,012...77,698,116
Ensembl chr13:77,698,012...77,698,116
|
|
G |
MIR424 |
microRNA 424 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR424 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:134,546,614...134,546,711
Ensembl chr X:134,546,614...134,546,711
|
|
G |
MIR4271 |
microRNA 4271 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR4271 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:49,274,120...49,274,186
Ensembl chr 3:49,274,120...49,274,186
|
|
G |
MIR4281 |
microRNA 4281 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR4281 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:176,629,439...176,629,500
Ensembl chr 5:176,629,439...176,629,500
|
|
G |
MIR454 |
microRNA 454 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR454 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:59,137,758...59,137,872
Ensembl chr17:59,137,758...59,137,872
|
|
G |
MIR542 |
microRNA 542 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MIR542 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:134,541,341...134,541,437
Ensembl chr X:134,541,341...134,541,437
|
|
G |
MIR574 |
microRNA 574 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR574 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:38,868,032...38,868,127
Ensembl chr 4:38,868,032...38,868,127
|
|
G |
MIR629 |
microRNA 629 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR629 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr15:70,079,372...70,079,468
Ensembl chr15:70,079,372...70,079,468
|
|
G |
MIR766 |
microRNA 766 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR766 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:119,646,738...119,646,848
Ensembl chr X:119,646,738...119,646,848
|
|
G |
MIR933 |
microRNA 933 |
increases expression |
EXP |
potassium bromate results in increased expression of MIR933 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:175,167,633...175,167,709
Ensembl chr 2:175,167,633...175,167,709
|
|
G |
MMP15 |
matrix metallopeptidase 15 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr16:58,025,754...58,046,901
Ensembl chr16:58,025,754...58,046,901
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of MMP2 protein Squalene inhibits the reaction [potassium bromate results in increased expression of MMP2 protein] |
CTD |
PMID:33219891 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MT1X |
metallothionein 1X |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of MT1 mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of MT1 mRNA] |
CTD |
PMID:27074584 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA] |
CTD |
PMID:27074584 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MTHFD2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
ISO |
potassium bromate results in increased expression of MTHFD2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565
|
|
G |
MUC1 |
mucin 1, cell surface associated |
decreases expression |
EXP |
potassium bromate results in decreased expression of MUC1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
|
|
G |
MUTYH |
mutY DNA glycosylase |
decreases expression |
EXP |
potassium bromate results in decreased expression of MUTYH mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 1:45,329,242...45,340,440
Ensembl chr 1:45,329,163...45,340,893
|
|
G |
MYH1 |
myosin heavy chain 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr17:10,492,307...10,518,542
Ensembl chr17:10,492,307...10,518,542
|
|
G |
MYH2 |
myosin heavy chain 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr17:10,521,148...10,549,658
Ensembl chr17:10,521,148...10,549,700
|
|
G |
MYLK3 |
myosin light chain kinase 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MYLK3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr16:46,702,282...46,763,246
Ensembl chr16:46,702,282...46,790,407
|
|
G |
NEBL |
nebulette |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NEBL mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:20,779,973...21,293,050
Ensembl chr10:20,779,973...21,293,011
|
|
G |
NPR3 |
natriuretic peptide receptor 3 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NPR3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:32,690,872...32,791,720
Ensembl chr 5:32,689,070...32,791,724
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
potassium bromate results in increased expression of NQO1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
OGG1 |
8-oxoguanine DNA glycosylase |
decreases response to substance increases response to substance |
ISO EXP |
OGG1 gene mutant form results in decreased susceptibility to potassium bromate OGG1 protein results in increased susceptibility to potassium bromate |
CTD |
PMID:25693136 PMID:34196753 |
|
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
|
|
G |
OSTN |
osteocrin |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:191,199,241...191,265,615
Ensembl chr 3:191,199,241...191,265,615
|
|
G |
PHGDH |
phosphoglycerate dehydrogenase |
decreases expression |
EXP |
potassium bromate results in decreased expression of PHGDH mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218
|
|
G |
PLCH2 |
phospholipase C eta 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:2,415,943...2,505,532
Ensembl chr 1:2,425,980...2,505,532
|
|
G |
PNKP |
polynucleotide kinase 3'-phosphatase |
decreases expression |
EXP |
potassium bromate results in decreased expression of PNKP mRNA |
CTD |
PMID:22539617 |
|
NCBI chr19:49,861,204...49,867,576
Ensembl chr19:49,859,882...49,878,351
|
|
G |
PPM1D |
protein phosphatase, Mg2+/Mn2+ dependent 1D |
increases expression |
EXP |
potassium bromate results in increased expression of PPM1D mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:60,600,193...60,666,280
Ensembl chr17:60,600,193...60,666,280
|
|
G |
PPP1R15A |
protein phosphatase 1 regulatory subunit 15A |
decreases methylation |
EXP |
potassium bromate results in decreased methylation of PPP1R15A promoter |
CTD |
PMID:30559759 |
|
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
|
|
G |
PRG4 |
proteoglycan 4 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of PRG4 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PRG4 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:186,296,273...186,314,567
Ensembl chr 1:186,296,279...186,314,567
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of PTGS2 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA]; vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mRNA] |
CTD |
PMID:26296324 PMID:27082013 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTPN22 |
protein tyrosine phosphatase non-receptor type 22 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of PTPN22 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PTPN22 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
|
|
G |
RAB3GAP2 |
RAB3 GTPase activating non-catalytic protein subunit 2 |
increases expression |
ISO |
potassium bromate results in increased expression of RAB3GAP2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:220,148,293...220,272,453
Ensembl chr 1:220,148,293...220,272,529
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression |
ISO |
Squalene inhibits the reaction [potassium bromate results in increased expression of RELA protein] |
CTD |
PMID:33219891 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
REN |
renin |
increases expression |
ISO |
potassium bromate results in increased expression of REN1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
|
|
G |
RETN |
resistin |
decreases expression |
ISO |
potassium bromate results in decreased expression of RETN mRNA |
CTD |
PMID:23588252 |
|
NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
|
|
G |
ROBO3 |
roundabout guidance receptor 3 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of ROBO3 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of ROBO3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr11:124,865,432...124,881,471
Ensembl chr11:124,865,432...124,881,471
|
|
G |
RPS27L |
ribosomal protein S27 like |
increases expression |
EXP |
potassium bromate results in increased expression of RPS27L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
|
|
G |
RRM2B |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
EXP |
potassium bromate results in increased expression of RRM2B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:102,204,501...102,238,961
Ensembl chr 8:102,204,502...102,238,961
|
|
G |
S100A8 |
S100 calcium binding protein A8 |
increases expression |
ISO |
potassium bromate results in increased expression of S100A8 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
|
|
G |
S100A9 |
S100 calcium binding protein A9 |
decreases expression |
ISO |
potassium bromate results in decreased expression of S100A9 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
|
|
G |
SAA3P |
serum amyloid A3, pseudogene |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SAA3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132 Ensembl chr11:18,112,472...18,116,132
|
|
G |
SCD |
stearoyl-CoA desaturase |
decreases expression |
ISO |
potassium bromate results in decreased expression of SCD1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
|
|
G |
SERTAD1 |
SERTA domain containing 1 |
increases expression |
EXP |
potassium bromate results in increased expression of SERTAD1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:40,421,589...40,425,992
Ensembl chr19:40,421,589...40,425,992
|
|
G |
SESN1 |
sestrin 1 |
increases expression |
EXP |
potassium bromate results in increased expression of SESN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,094,846
|
|
G |
SFN |
stratifin |
increases expression |
EXP |
potassium bromate results in increased expression of SFN mRNA |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
|
|
G |
SLC26A4 |
solute carrier family 26 member 4 |
decreases expression |
ISO |
potassium bromate results in decreased expression of SLC26A4 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 7:107,660,828...107,717,809
Ensembl chr 7:107,660,828...107,717,809
|
|
G |
SLC26A7 |
solute carrier family 26 member 7 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SLC26A7 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 8:91,209,496...91,398,155
Ensembl chr 8:91,209,494...91,398,155
|
|
G |
SLC7A11 |
solute carrier family 7 member 11 |
increases expression |
EXP |
potassium bromate results in increased expression of SLC7A11 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
|
|
G |
SLC7A5 |
solute carrier family 7 member 5 |
increases expression |
EXP |
potassium bromate results in increased expression of SLC7A5 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
|
|
G |
SLCO2B1 |
solute carrier organic anion transporter family member 2B1 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of SLCO2B1 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of SLCO2B1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
|
|
G |
SOD1 |
superoxide dismutase 1 |
increases activity decreases activity multiple interactions |
EXP ISO |
potassium bromate results in increased activity of SOD1 protein potassium bromate results in decreased activity of SOD1 protein Arbutin inhibits the reaction [potassium bromate results in decreased activity of SOD1 protein] |
CTD |
PMID:22012894 PMID:36284482 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions increases expression |
EXP |
ceric oxide inhibits the reaction [potassium bromate results in increased expression of SOD2 mRNA] |
CTD |
PMID:25618551 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SPATA22 |
spermatogenesis associated 22 |
decreases expression |
ISO |
potassium bromate results in decreased expression of SPATA22 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr17:3,440,019...3,513,858
Ensembl chr17:3,440,019...3,513,852
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
increases expression |
ISO EXP |
potassium bromate results in increased expression of SPP1 mRNA; potassium bromate results in increased expression of SPP1 protein |
CTD |
PMID:23588252 PMID:23811332 PMID:30008028 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SQSTM1 |
sequestosome 1 |
increases expression |
EXP |
potassium bromate results in increased expression of SQSTM1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SRXN1 |
sulfiredoxin 1 |
increases expression |
ISO EXP |
potassium bromate results in increased expression of SRXN1 mRNA |
CTD |
PMID:22003191 PMID:30008028 |
|
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
|
|
G |
SULT2A1 |
sulfotransferase family 2A member 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SULT2A1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
|
|
G |
TIGAR |
TP53 induced glycolysis regulatory phosphatase |
increases expression |
EXP |
potassium bromate results in increased expression of TIGAR mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:4,321,213...4,360,028
Ensembl chr12:4,307,763...4,360,028
|
|
G |
TK1 |
thymidine kinase 1 |
increases mutagenesis |
ISO |
potassium bromate results in increased mutagenesis of TK1 gene |
CTD |
PMID:19853637 |
|
NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233
|
|
G |
TMEM163 |
transmembrane protein 163 |
decreases expression |
ISO |
potassium bromate results in decreased expression of TMEM163 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:134,455,759...134,719,000
Ensembl chr 2:134,455,759...134,719,000
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFSF9 |
TNF superfamily member 9 |
increases expression |
EXP |
potassium bromate results in increased expression of TNFSF9 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:6,531,026...6,535,924
Ensembl chr19:6,531,026...6,535,924
|
|
G |
TNS1 |
tensin 1 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:217,799,791...218,033,982
Ensembl chr 2:217,799,588...218,033,982
|
|
G |
TOP3B |
DNA topoisomerase III beta |
decreases expression |
EXP |
potassium bromate results in decreased expression of TOP3B mRNA |
CTD |
PMID:22539617 |
|
NCBI chr22:21,957,025...21,982,787
Ensembl chr22:21,957,025...21,982,813
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions increases phosphorylation |
EXP ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein] |
CTD |
PMID:20067818 PMID:25015661 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TP53INP1 |
tumor protein p53 inducible nuclear protein 1 |
increases methylation increases expression |
EXP |
potassium bromate results in increased methylation of TP53INP1 promoter potassium bromate results in increased expression of TP53INP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:94,925,972...94,949,378
Ensembl chr 8:94,925,972...94,949,378
|
|
G |
TRIAP1 |
TP53 regulated inhibitor of apoptosis 1 |
increases expression |
EXP |
potassium bromate results in increased expression of TRIAP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:120,443,964...120,446,384
Ensembl chr12:120,443,964...120,446,384
|
|
G |
TRIB3 |
tribbles pseudokinase 3 |
increases expression |
ISO EXP |
potassium bromate results in increased expression of TRIB3 mRNA |
CTD |
PMID:23588252 PMID:30008028 |
|
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
|
|
G |
UBD |
ubiquitin D |
increases expression |
ISO |
potassium bromate results in increased expression of UBD mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions increases expression |
ISO |
Squalene inhibits the reaction [potassium bromate results in increased expression of VEGFA protein] |
CTD |
PMID:33219891 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VIT |
vitrin |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of VIT mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of VIT mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:36,696,707...36,814,794
Ensembl chr 2:36,696,690...36,814,794
|
|
G |
WARS1 |
tryptophanyl-tRNA synthetase 1 |
decreases expression |
EXP |
potassium bromate results in decreased expression of WARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr14:100,333,790...100,376,327
Ensembl chr14:100,333,790...100,376,805
|
|
G |
XDH |
xanthine dehydrogenase |
increases activity multiple interactions |
ISO |
potassium bromate results in increased activity of XDH protein Taurine inhibits the reaction [potassium bromate results in increased activity of XDH protein] |
CTD |
PMID:25213677 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|
G |
XRCC3 |
X-ray repair cross complementing 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of XRCC3 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr14:103,697,617...103,715,451
Ensembl chr14:103,697,609...103,715,504
|
|
G |
XRCC6 |
X-ray repair cross complementing 6 |
multiple interactions increases response to substance |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CCL20 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CXCL3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of DSC1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of FRY mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HCAR2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HPGD mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NEBL mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NPR3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SAA3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SLC26A7 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of WFDC17 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BLNK mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BMF mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IKZF2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PTPN22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of VIT mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein; bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein] |
CTD |
PMID:25693136 PMID:27082013 |
|
NCBI chr22:41,621,295...41,664,041
Ensembl chr22:41,621,163...41,664,048
|
|
G |
ZMAT3 |
zinc finger matrin-type 3 |
increases expression |
EXP |
potassium bromate results in increased expression of ZMAT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:179,017,223...179,072,513
Ensembl chr 3:178,960,121...179,072,215
|
|